Antiviral treatment in pregnant women with chronic hepatitis B infection,International Journal of Epidemiology

当前位置： X-MOL 学术 › Int. J. Epidemiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Antiviral treatment in pregnant women with chronic hepatitis B infection
International Journal of Epidemiology ( IF 6.4 ) Pub Date : 2018-10-31 , DOI: 10.1093/ije/dyy241
Songxu Peng ₁ , Yukai Du ₁

Affiliation

We read with interest the article by Cui et al.¹ regarding antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus (HBV) in China. Their study found that identifying high-risk pregnant women and providing them with antiviral treatment is advisable and cost-effective to interrupt mother-to-child transmission of HBV. Their results add value to the efforts to develop national and regional treatment programmes that will help to achieve the WHO global elimination goal of 0.1% hepatitis B surface antigen (HBsAg) prevalence among children by 2030.

更新日期：2018-10-31

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11